Product Information
VARENICLINE 0.5 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.3116 per EA under NDC 72603047601. Its NADAC has been published 88 times since Jan 29, 2025.
FDA first approved this application on Oct 23, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
NorthStar Rx LLCNDC
72603047601
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VARENICLINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA214571FDA Approved
10/23/2023
TE Code
AB
On Market Since
9/23/2024
Pharmacological Classes
Price Statistics
The NADAC for VARENICLINE 0.5 MG TABLET has been published 88 times since Jan 29, 2025, and over the history we have for it it has declined 46.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3116 per EA |
|---|---|
| All-time high | $0.7722 (May 14, 2025) |
| All-time low | $0.3116 (Sep 23, 2026) |
| 52-week high | $0.4562 |
| 52-week low | $0.3116 |
| Median price | $0.3802 |
| Average price | $0.4808 |
| Largest weekly change | +18.1% (Jul 22, 2026) |
| Weeks tracked | 88 |
| Tracking since | Jan 29, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Varenicline tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VARENICLINE 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VARENICLINE 0.5 MG TABLET, manufactured by NorthStar Rx LLC, is $0.3116 per EA (NDC 72603047601), effective Sep 30, 2026.
How has the price of VARENICLINE 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for VARENICLINE 0.5 MG TABLET has declined 46.8%. It has been tracked across 88 weekly CMS publications since Jan 29, 2025.
What are the highest and lowest recorded NADAC prices for VARENICLINE 0.5 MG TABLET?
Since Jan 29, 2025, the NADAC for VARENICLINE 0.5 MG TABLET has ranged from a low of $0.3116 (Sep 23, 2026) to a high of $0.7722 (May 14, 2025), with a median of $0.3802 per EA.
Are there cheaper alternatives to VARENICLINE 0.5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VARENICLINE 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VARENICLINE 0.5 MG TABLET?
VARENICLINE 0.5 MG TABLET (NDC 72603047601) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.